A citation-based method for searching scientific literature

Panchanan Maiti, Jayeeta Manna, Gary L Dunbar. Transl Neurodegener 2017
Times Cited: 198







List of co-cited articles
767 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
11

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
10

The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
883
9

Mitochondrial Dysfunction in Parkinson's Disease-Cause or Consequence?
Chun Chen, Doug M Turnbull, Amy K Reeve. Biology (Basel) 2019
113
8

Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Jin-Sung Park, Ryan L Davis, Carolyn M Sue. Curr Neurol Neurosci Rep 2018
241
7

Parkinson's Disease and the Environment.
Nicole Ball, Wei-Peng Teo, Shaneel Chandra, James Chapman. Front Neurol 2019
136
7

Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
Fatemeh N Emamzadeh, Andrei Surguchov. Front Neurosci 2018
175
7

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?
Amy Reeve, Eve Simcox, Doug Turnbull. Ageing Res Rev 2014
411
7

Oxidative stress and Parkinson's disease.
Javier Blesa, Ines Trigo-Damas, Anna Quiroga-Varela, Vernice R Jackson-Lewis. Front Neuroanat 2015
448
7

Mitochondrial complex I deficiency in Parkinson's disease.
A H Schapira, J M Cooper, D Dexter, J B Clark, P Jenner, C D Marsden. J Neurochem 1990
7

The genetic architecture of Parkinson's disease.
Cornelis Blauwendraat, Mike A Nalls, Andrew B Singleton. Lancet Neurol 2020
293
7


The many faces of α-synuclein: from structure and toxicity to therapeutic target.
Hilal A Lashuel, Cassia R Overk, Abid Oueslati, Eliezer Masliah. Nat Rev Neurosci 2013
939
6

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
6

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
6

Amyloid beta: structure, biology and structure-based therapeutic development.
Guo-Fang Chen, Ting-Hai Xu, Yan Yan, Yu-Ren Zhou, Yi Jiang, Karsten Melcher, H Eric Xu. Acta Pharmacol Sin 2017
545
6

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
Xian-Si Zeng, Wen-Shuo Geng, Jin-Jing Jia, Lei Chen, Peng-Peng Zhang. Front Aging Neurosci 2018
104
6

Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
Ji-Dong Guo, Xin Zhao, Yang Li, Guang-Ren Li, Xiao-Liang Liu. Int J Mol Med 2018
126
6

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease.
Patrick P Michel, Etienne C Hirsch, Stéphane Hunot. Neuron 2016
308
6

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.
David K Simon, Caroline M Tanner, Patrik Brundin. Clin Geriatr Med 2020
176
6

Parkinson disease.
R Balestrino, A H V Schapira. Eur J Neurol 2020
298
6

Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
Sudhakar Raja Subramaniam, Marie-Francoise Chesselet. Prog Neurobiol 2013
366
6

Mitochondrial Dysfunction in Parkinson's Disease.
Hyo Eun Moon, Sun Ha Paek. Exp Neurobiol 2015
178
5

Parkinson's disease: animal models and dopaminergic cell vulnerability.
Javier Blesa, Serge Przedborski. Front Neuroanat 2014
295
5

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.
E R Dorsey, R Constantinescu, J P Thompson, K M Biglan, R G Holloway, K Kieburtz, F J Marshall, B M Ravina, G Schifitto, A Siderowf,[...]. Neurology 2007
5

Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
869
5



Protein misfolding in neurodegenerative diseases: implications and strategies.
Patrick Sweeney, Hyunsun Park, Marc Baumann, John Dunlop, Judith Frydman, Ron Kopito, Alexander McCampbell, Gabrielle Leblanc, Anjli Venkateswaran, Antti Nurmi,[...]. Transl Neurodegener 2017
259
5


Mitochondrial dysfunction in neurodegenerative diseases.
Ashu Johri, M Flint Beal. J Pharmacol Exp Ther 2012
402
4

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.
Michelle L Block, Luigi Zecca, Jau-Shyong Hong. Nat Rev Neurosci 2007
4

Autophagy in Parkinson's Disease.
Xu Hou, Jens O Watzlawik, Fabienne C Fiesel, Wolfdieter Springer. J Mol Biol 2020
97
4

The SH-SY5Y cell line in Parkinson's disease research: a systematic review.
Helena Xicoy, Bé Wieringa, Gerard J M Martens. Mol Neurodegener 2017
390
4

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.
Delphine Charvin, Rossella Medori, Robert A Hauser, Olivier Rascol. Nat Rev Drug Discov 2018
109
4

Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
4

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
Joseph R Mazzulli, You-Hai Xu, Ying Sun, Adam L Knight, Pamela J McLean, Guy A Caldwell, Ellen Sidransky, Gregory A Grabowski, Dimitri Krainc. Cell 2011
887
4

The 6-hydroxydopamine model of Parkinson's disease.
Nicola Simola, Micaela Morelli, Anna R Carta. Neurotox Res 2007
241
4

Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation.
Francesca Magrinelli, Alessandro Picelli, Pierluigi Tocco, Angela Federico, Laura Roncari, Nicola Smania, Giampietro Zanette, Stefano Tamburin. Parkinsons Dis 2016
127
4

α-Synuclein in Parkinson's disease.
Leonidas Stefanis. Cold Spring Harb Perspect Med 2012
633
4

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.
Sangjune Kim, Seung-Hwan Kwon, Tae-In Kam, Nikhil Panicker, Senthilkumar S Karuppagounder, Saebom Lee, Jun Hee Lee, Wonjoong Richard Kim, Minjee Kook, Catherine A Foss,[...]. Neuron 2019
506
4

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
4


Toxin models of mitochondrial dysfunction in Parkinson's disease.
Terina N Martinez, J Timothy Greenamyre. Antioxid Redox Signal 2012
141
4

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Wei Zhang, Tongguang Wang, Zhong Pei, David S Miller, Xuefei Wu, Michelle L Block, Belinda Wilson, Wanqin Zhang, Yong Zhou, Jau-Shyong Hong,[...]. FASEB J 2005
866
4

Genetics of Parkinson's disease.
Christine Klein, Ana Westenberger. Cold Spring Harb Perspect Med 2012
687
4

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
Anne-Laure Mahul-Mellier, Johannes Burtscher, Niran Maharjan, Laura Weerens, Marie Croisier, Fabien Kuttler, Marion Leleu, Graham W Knott, Hilal A Lashuel. Proc Natl Acad Sci U S A 2020
218
4

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.